Twitter Beğeni Hilesi

Developing safe and effective allogeneic CAR-T cell therapies has been a long-standing focus for SCI member, Melody Smith. stan.md/3WETnXD Melody Smith, MD, MS #CellTherapy

SCI member Calvin Kuo and others show that chemo-resistant #PancreaticCancer can be reversed and reveal potential targets for new pancreatic cancer treatments. stanford.io/4foGbxi

SCI member James Zou and others have developed a new AI tool that identifies diseased cells under the microscope and can be easily customized by any pathologist. stanford.io/3AjGVU8 #AIhealthcare James Zou

Sequencing the human genome at an increasingly faster rate has improved treatment efficacy at less cost to the patient. Steven Artandi, MD, PhD speaks about some of the possibilities genomics in oncology has uncovered for patients with cancer. bit.ly/4cdaPaa #genomics #oncology

SCI leader Nathanael Gray explains how an increased understanding of the underlying mechanisms of cancer, cutting-edge technologies, and team science are helping Stanford researchers develop novel cancer drugs. stan.md/3YF479T #DrugDiscovery

Dermatologist, Leandra Barnes, MD, is launching Stanford Medicine's first Skin of Color program. The initiative is designed to provide a welcoming environment for diverse skin conditions while advancing research, training, and advocacy. stan.md/4d68YVP #SkinCancer

Parents: Ask for the #HPVvaccine at your child’s back-to-school doctor visit. The HPV vaccine is most effective when given to all children 9-12-years-old. Learn more: bit.ly/3WYpUYP

Increased #CancerScreens create more work for oncologists; however, Steven Artandi, MD, PhD predicts that these changes will reduce burnout and workload for physicians in the long term. bit.ly/4ckZRiN

In this new overview video, Steven Artandi, MD, PhD breaks down why the Stanford Cancer Institute has developed a robust network strategy to create new clinics in patients’ own neighborhoods. bit.ly/4fJiQGU #diversityinmedicine #cancercare #stanfordcancer

SCI members Matthew Frank & David Miklos have found that a new CAR-T cell therapy that targets a different protein on the surface of the cancer cells significantly improved patients’ outcomes. stan.md/3AxL1YX #CellTherapy

At Stanford, we’ve developed our proprietary CAR T technology showing incredible responses in solid tumors. Steven Artandi, MD, PhD speaks to some of the incredible advances in CAR T-cell therapy our team at Stanford has made. bit.ly/3YQbKdH

Congratulations to SCI member @Corsellos for being named a 2024 Damon Runyon Cancer Research Foundation Clinical Investigator! He is investigating how to simultaneously activate inflammatory signaling and cell death pathways to develop less toxic therapies for #PancreaticCancer. bit.ly/3M91iGu

Clinical research is particularly important in the field of oncology, where new discoveries are being made every day. At Stanford, our patients are among the first in the nation to receive newly developed therapies. Steven Artandi, MD, PhD explains how: bit.ly/3YNxDu3

Congratulations to the 2024 SCI Equity Impact Research Grants awardees! View their innovative projects here: stan.md/4dy1CL2 Heather Wakelee Summer Han Allison Kurian Jennifer Caswell-Jin

SCI member Kavitha Ramchandran explains the difference between malignant and benign tumors in the brain, shares the different types of brain tumors including #gliomas and #meningiomas. bit.ly/3Z3oa1W #BrainCancer

Stanford Medicine scientists who study #PFAS say there are a few small steps that an average person can take to lower their personal exposure. New government regulations will be key to lowering PFAS exposure & associated health outcomes. stan.md/3Z3EwYk #foreverchemicals

Join us!

Stanford's Bryant Lin dedicated his career to research on #LungCancer among Asian American non-smokers. Now facing the disease himself, he will teach a course this fall titled "MED 275: From Diagnosis to Dialogue." bit.ly/3z8Um9y

Patients from Stanford Children's had the honor of standing next to their favorite SFGiants players during Pediatric Cancer Awareness Day at Oracle Park. For 6-year-old Rhett, it's a moment he'll never forget as it marks a turning point in his cancer journey. bit.ly/4e8l1Ss

Congratulations to our SCI Innovation Awardees! Their groundbreaking research will drive advances in basic, translational, clinical, and population-based #CancerResearch. Learn more:  stan.md/4egVMxv #StanfordCancer